Equities

Jupiter Bioscience Ltd

JUPITER:NSI

Jupiter Bioscience Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)4.15
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 11 2013.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2011201120102009
ASSETS
Cash And Short Term Investments436014
Total Receivables, Net1,024777713
Total Inventory779684576
Prepaid expenses21513572
Other current assets, total24329.32
Total current assets2,0851,6891,384
Property, plant & equipment, net7,7256,2414,626
Goodwill, net------
Intangibles, net823623595
Long term investments3,00517596
Note receivable - long term------
Other long term assets------
Total assets13,6388,7296,701
LIABILITIES
Accounts payable1019870
Accrued expenses115.495.49
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total23889133
Total current liabilities349193208
Total long term debt4,4754,2042,938
Total debt4,4754,2042,938
Deferred income tax278249204
Minority interest------
Other liabilities, total------
Total liabilities5,1024,6463,350
SHAREHOLDERS EQUITY
Common stock645182161
Additional paid-in capital7,0953,3652,758
Retained earnings (accumulated deficit)795535432
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity8,5364,0823,351
Total liabilities & shareholders' equity13,6388,7296,701
Total common shares outstanding621816
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.